1. 4CPS-113 Drug cost saving resulting from metastatic melanoma clinical trials. (March 2019) Authors: García Moreno, FJ; González-Haba Peña, E; Sánchez Fresneda, MN; García Martín, E; García Sánchez, S; Marzal Alfaro, B; Collado Borrell, R; Mur Mur, A; Herranz Alonso, A; Sanjurjo Sáez, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DI-030 Prescription profile of abiraterone in metastatic prostate carcinoma. (24th February 2014) Authors: Escudero-Vilaplana, V; Ribed Sánchez, A; González Haba, E; Sánchez Fresneda, MN; Buendía Bravo, S; Ais Larisgoitia, A; Marquínez Alonso, I; García González, X; Sanjurjo Sáez, M Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗